Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1988-07-08
1991-03-19
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424448, 424449, A61K 1300
Patent
active
050009567
ABSTRACT:
A method of preventing sensitization in transdermal drug delivery by the inclusion of a corticosteroid, which wll be co-extensively coadministered with the sensitizing agent.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 4130643 (1978-12-01), Smith
patent: 4144317 (1979-03-01), Higuchi et al.
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4292303 (1981-09-01), Keith et al.
patent: 4314557 (1982-02-01), Chandrasekaran
patent: 4343798 (1982-08-01), Fawzi
patent: 4353896 (1982-10-01), Levy
patent: 4362737 (1982-12-01), Schafer et al.
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4548922 (1985-10-01), Carey et al.
patent: 4559222 (1985-12-01), Enscore et al.
patent: 4573995 (1986-03-01), Cheng et al.
patent: 4608249 (1986-08-01), Otsuka et al.
patent: 4634766 (1987-01-01), Atkinson et al.
Drug Information 86, 84:06 "Anti-Inflammatory Agents: Topical Corticosteroids General Statement" pp. 1780-1782, American Hospital Formulary Service.
J. Foussereau, C. Benezra, H. I. Maibach & N. Hjorth, "Occupational Contact Dermatitis, Clinical and Chemical Aspects," (W. B. Saunders Company 1982).
B. W. Barry and D. I. D. El Eini, "Influence of Non-ionic Surfactants on Permeation of Hydrocortisone, Dexamethasone, Testosterone and Progesterone Across Cellulose Acetate Membrane," J. Pharm. Pharmac. 28, pp. 219-227 (1976).
J. Fachet et al., "Effect of Corticosteroids and Adult Thymectomy on Induction and Recall of Contact Sensitivity in Mice," Clin. Exp. Immunol 10, pp. 661-692 (1972).
Geoffrey Zubay, Biochemistry, pp. 535-543 (1983).
B. Samuelsson, "Leubotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation," Science, vol. 220, pp. 568-575, May 1983.
AMA Drug Evaluations, 5th edition, pp. 1441-1442.
D. V. Belsito et al., "Effect of Glucocorticosteroids on Epidermal Langerhans Cells," J. Exp. Med., vol. 155, pp. 291-302 (Jan. 1982).
W. M. Burrows et al., "Inhibition of Induction of Human Contact Sensitization by Topical Glucocorticosteroid," Arch Dermatol, vol. 112, p. 175-178 (Feb. 1986).
B. Berman et al., "Modulation of Expression of Epidermal Langerhans Cell Properties Following in Site Exposure to Glucocorticosteroids," The Journal of Investigative Dermatology, vol. 80, No. 3, pp. 168-171 (1983).
"Contact Dermatitis due to Nitroglycerin Ointment," A. A. Hendricks and G. W. Dec Arch. Dermatol. 115: 853-855 (1979).
Amkraut Alfred
Shaw Jane E.
ALZA Corporation
Cashion Jr. Merrell C.
Horne Leon R.
Mandell Edward L.
Miller D. Byron
LandOfFree
Prevention of contact allergy by coadministration of a corticost does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of contact allergy by coadministration of a corticost, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of contact allergy by coadministration of a corticost will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2008994